FMO5 and type 2 diabetes mellitus: As shown in Fig. 2 and Table 1, a total of 1661 cases (patients with T2DM) and 1265 controls (healthy subjects) were identified for analysis of the association between the NAD(P)H oxidase p22 phox gene C242T polymorphism and T2DM risk.